Literature DB >> 24394826

Transitional care management reimbursement to reduce COPD readmission.

Shreya Kangovi1, David Grande2.   

Abstract

Reducing preventable readmissions for COPD is an important national health policy goal. Thus far, Centers for Medicare & Medicaid Services (CMS) policies focused on incentivizing improvements in inpatient quality have had variable success. In its 2013 physician-payment rule, CMS announced new payments that reimburse ambulatory care providers for timely posthospital visits and transitional care management services. CMS hopes that posthospital transitional care and services will substitute for readmission, but the evidence supporting this hypothesis is mixed. In this article, we discuss ways for ambulatory pulmonologists to leverage transitional care management payments to enhance access for their patients with COPD while minimizing the risk of a paradoxic increase in readmission rates.

Entities:  

Mesh:

Year:  2014        PMID: 24394826     DOI: 10.1378/chest.13-0787

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  4 in total

1.  Integrating COPD into Patient-Centered Hospital Readmissions Reduction Programs.

Authors:  Jerry A Krishnan; Hélène A Gussin; Valentin Prieto-Centurion; Jamie L Sullivan; Farhan Zaidi; Byron M Thomashow
Journal:  Chronic Obstr Pulm Dis       Date:  2015

Review 2.  Hierarchical Condition Categories for Pulmonary Diseases: Population Health Management and Policy Opportunities.

Authors:  Gary E Weissman
Journal:  Chest       Date:  2019-01-16       Impact factor: 9.410

3.  Hospital discharges, readmissions, and ED visits for COPD or bronchiectasis among US adults: findings from the nationwide inpatient sample 2001-2012 and Nationwide Emergency Department Sample 2006-2011.

Authors:  Earl S Ford
Journal:  Chest       Date:  2015-04       Impact factor: 9.410

Review 4.  Hepatic Encephalopathy-Related Hospitalizations in Cirrhosis: Transition of Care and Closing the Revolving Door.

Authors:  Catherine T Frenette; Cynthia Levy; Sammy Saab
Journal:  Dig Dis Sci       Date:  2021-06-24       Impact factor: 3.487

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.